prostate cancer index | prostate cancer | prostatectomy | radiation | hormone | cryosurgery | hifu | wait & see | alternative treatment | diet | articles | contact |

Archive for the ‘watchful waiting’ Category

Study shows monitoring can be the best treatment for men with prostate cancer of low-risk type

Saturday, June 26th, 2010 Posted in watchful waiting | No Comments »

According to a study now being published in the Journal of the National Cancer Institute, monitoring can be the best treatment for men with prostate cancer of the low-risk type. How local prostate cancer, that is, cancer that has not spread ...

Prostate tumors not likely to worsen during active surveillance period in low risk patients

Wednesday, June 9th, 2010 Posted in watchful waiting | No Comments »

Johns Hopkins experts have found that men enrolled in an active surveillance program for prostate cancer that eventually needed surgery to remove their prostates fared just as well as men who opted to remove the gland immediately, except if a ...

‘Watchful waiting’ may be option for some men

Tuesday, June 1st, 2010 Posted in watchful waiting | No Comments »

Recent years are overwhelmed whether doctors are treating prostate cancer when they don't need to. In some cases, doctors use "watchful waiting" to monitor patients to see if signs of prostate cancer worsen. A recent research is offering more light into the ...

Questions regarding selection of patients for active surveillance at VA medical centers

Friday, May 28th, 2010 Posted in watchful waiting | No Comments »

A recent study at University of California-San Diego, reports that patients in the SEARCH database who would theoretically have been eligible for active surveillance (AS) for low-risk prostate cancer were actually at increased risk for recurrence if they were of ...

Many have low distress during prostate cancer surveillance

Thursday, May 20th, 2010 Posted in watchful waiting | No Comments »

According to research published in the May issue of The Journal of Urology, men with low-risk prostate cancer on active surveillance generally have favorably low anxiety and distress in the first nine months of surveillance. Researchers of the Erasmus Medical Center ...

PSA kinetics do not predict pathology in men on active surveillance

Tuesday, May 4th, 2010 Posted in watchful waiting | 1 Comment »

A new study at Johns Hopkins University School of Medicine aimed to assess the predictive ability of prostate-specific antigen (PSA) velocity (PSAV) and doubling time (PSADT) for biopsy progression and adverse pathology at prostatectomy among men with low-risk prostate cancer ...

New guideline endorses active surveillance

Thursday, April 8th, 2010 Posted in watchful waiting | No Comments »

In its new guidelines, National Comprehensive Cancer Network (NCCN), an alliance of 21 leading cancer centers across the U.S, recommends active surveillance for men deemed to have "very low risk" prostate cancer and a life expectancy of less than 20 ...

Watchful waiting not distressing for most prostate patients

Wednesday, March 31st, 2010 Posted in watchful waiting | No Comments »

New research at Erasmus Medical Center in Rotterdam, The Netherlands shows "watchful waiting" for disease progression won't make men with slow-growing prostate cancer more anxious or distressed, especially if they're in relatively good health otherwise and not too anxious to ...

New update of active surveillance for prostate cancer

Sunday, March 21st, 2010 Posted in watchful waiting | No Comments »

Active surveillance, also referred to as watchful waiting, is a viable option for many men with low risk prostate cancer although the concept continues to cause distress and confusion In a long media release recently, the National Comprehensive Cancer Network (NCCN), ...

NCCN updates prostate cancer management guidance

Saturday, January 9th, 2010 Posted in watchful waiting | No Comments »

The updated NCCN clinical guidelines now include an explicit recommendation for active surveillance (watchful waiting) and only active surveillance for many men diagnosed with prostate cancer. [ more about active surveillance and prostate cancer treatment ]